SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 20, 2003
HAEMONETICS CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Massachusetts 1-10730 04-288 2273
------------- ------- -----------
(State or other jurisdiction of (Commission File (IRS Employer
incorporation or organization) Number) Identification Number)
400 Wood Road
Braintree, MA 02184
(Address of principal executive (Zip Code)
offices)
Registrant's telephone number, including area code (781) 848-7100
Item 5. Other Events and Regulation FD Disclosure
---------------------------------------------------
On August 20, 2003, Haemonetics Corporation (the "Company"), announced the
appointments of Peter M. Allen and Brian Concannon, respectively, as
Presidents of its newly created Donor and Patient Divisions.
Item 7. Financial Statements and Exhibits.
--------------------------------------------
(c) Exhibits.
---------
99.1 Press Release of the Company dated August 20, 2003.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
HAEMONETICS CORPORATION
Date: August 20, 2003 By: s/Brad Nutter
--------------- -------------------------------
Brad Nutter, President
and Chief Executive Officer
3